华东医药：2024年第一季度报告（英文版）.PDF

1、First Quarterly Report 2024 of Huadong Medicine Co.,Ltd.1 Security code:000963 Stock abbreviation:Huadong Medicine Announcement No.:2024-041 Huadong Medicine Co.,Ltd.First Quarterly Report 2024 The Company and all members of the Board of Directors hereby guarantee that the information presented in t

2、his report is authentic,accurate and complete and free of any false records,misleading statements or material omissions.Important Declaration:1.The Board of Directors,Board of Supervisors,directors,supervisors and senior management of Huadong Medicine Co.,Ltd.(hereinafter referred to as the Company)

3、hereby guarantee that the information presented in this report is authentic,accurate and complete and free of false records,misleading statements or material omissions,and shall undertake individual and joint legal liabilities.2.The Companys legal representative,the officer in charge of accounting,a

4、nd the head of accounting department(accounting supervisor)hereby declare that the financial information in this quarterly report is authentic,accurate and complete.3.Has the First Quarterly Report been audited?Yes No According to“Stock Listing Rules of the Shenzhen Stock Exchange”,if listed compani

5、es have both Chinese and other language version of public notice,they should ensure the content of both versions are the same.In the case of discrepancy,the original version in Chinese shall prevail.First Quarterly Report 2024 of Huadong Medicine Co.,Ltd.2 I.Key Financial Data(I)Key accounting data

6、and financial indicators Does the Company need to retroactively adjust or restate the accounting data of previous years?Yes No Current reporting period Same period last year Increase or decrease during the current reporting period compared with the same period of last year(%)Operating revenue(RMB)10